Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Eli Lilly on Thursday launched in India its diabetes and weight-loss drug, Mounjaro, which has already clocked in over $20 ...

Eli Lilly and Co. has begun selling its blockbuster weight-loss and diabetes drug Mounjaro in India, pipping rivals in a ...

Eli Lilly (LLY) stock in focus as the company launches its weight loss therapy Mounjaro in India, beating its rival Novo Nordisk (NVO). Read more here.

What is the category of Nippon India Nifty Pharma ETF ? The category of Nippon India Nifty Pharma ETF is Equity - Sector - Healthcare What is the current NAV of Nippon India Nifty Pharma ETF ...

“The pharmaceutical industry is globalized: generic drugs manufactured at sites in India will be produced using imported materials and be shipped to distributors worldwide, who will coordinate ...

Eli Lilly is a giant pharma company of America. This company has launched its blockbuster medicine for diabetes and obesity in India. Crores of people in India are suffering from the problem of ...

Eli Lilly, a giant US pharma company, has launched its blockbuster drug for diabetes and obesity in India. The name of this ...

Sun Pharmaceutical Industries or Sun Pharma is India’s leading pharmaceutical firm which is known for the production of Active Pharmaceutical Ingredients (APIs). The company is headquartered in ...

A ranking of the top songs based on streaming and sales activity from within the country- as tracked by Luminate. The ranking is based on a weighted formula incorporating official-only streams ...

In today’s fast-paced world, threats can evolve quickly and without warning. As the pharmaceutical industry has operations and supply chains spanning the globe, companies are vulnerable to ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.